Theralase Technologies Inc. (TLT)
TSX Venture Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 0.220 |
|---|---|
| 52-week range | 0.150 – 0.410 |
| Return, 1 month / 3 months | +22.2% / −15.4% |
| Return, 1 year / 3 years | +4.8% / −10.2% |
| Trend | Below its 200-day average |
| RSI (14) | 75 |
| Volatility (1 year) | 90.0% |
| Worst drawdown (1 year) | -53.8% |
| Average daily value traded | 0.05M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Theralase Technologies Inc. is a medical device and pharmaceutical company based in Toronto, Canada. It develops laser systems and light-activated drugs, with its main focus on a photodynamic compound that is delivered to tumours and then switched on by laser light to destroy cancer cells. The company also has a line of therapeutic laser devices used for pain relief and tissue healing in clinical settings. Its customers are mainly clinics, hospitals and cancer researchers taking part in its clinical studies.
Theralase Technologies Inc. trades under the code TLT on the TSX Venture Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Theralase Technologies Inc. (TLT) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.220 on 22 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 700 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.8% and over the last three months it fell 15.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.4% | ||
| From 52-week high | -43.6% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.4% | ||
| 6-month return | -35.3% | ||
| 12-month return, skipping the last month | -14.3% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 90.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.8% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 0.05M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +15.8% |
|---|---|
| 1 month | +22.2% |
| 3 months | −15.4% |
| 6 months | −35.3% |
| 1 year | +4.8% |
| 3 years | −10.2% |
| 5 years | +4.8% |
Signals
| 50-day / 200-day average | 0.186 / 0.248 |
|---|---|
| Golden / death cross (60 days) | Death, 43 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.009 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.